Carbamazepine
Brands: Carbatrol · Equetro · Carbamazepine
9 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 13 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bryant Ranch Prepack | repackager | 7 | SUPPLYING |
| Takeda Pharmaceuticals America, Inc. | unknown | 3 | SUPPLYING |
| Validus Pharmaceuticals LLC | unknown | 3 | SUPPLYING |
| ANI Pharmaceuticals, Inc. | unknown | 3 | SUPPLYING |
| Apotex Corp. | unknown | 3 | SUPPLYING |
| Coupler LLC | unknown | 3 | SUPPLYING |
| AvPAK | unknown | 3 | SUPPLYING |
| Major Pharmaceuticals | unknown | 1 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Dec 19, 2025RESOLVEDShortage resolved: Carbamazepine Capsule, Extended Release (Takeda Pharmaceuticals USA Inc.)
Carbamazepine Capsule, Extended Release — reported in shortage by Takeda Pharmaceuticals USA Inc.. Therapeutic category: Neurology.
- Dec 19, 2025SHORTAGEDrug shortage: Carbamazepine Capsule, Extended Release (Takeda Pharmaceuticals USA Inc.)
Carbamazepine Capsule, Extended Release — reported in shortage by Takeda Pharmaceuticals USA Inc.. Therapeutic category: Neurology.
Pill